Journal rankings · indicator year 2021
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2021
Endocrinology, Diabetes and Metabolism journal rankings 2021
163 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 163 ranked journals in 2021. The median OJR fell 0.06 on 2020 to 0.89, below the world average of 1.00; Q1 starts at OJR 1.35. The top three are Endocrine Reviews, The Lancet Diabetes & Endocrinology, and Diabetes Care.
Ranks and citation indicators: 2021. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2018–2020, the window the 2021 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery985
- Pulmonary and Respiratory Medicine362
- Public Health, Environmental and Occupational Health303
- Cardiology and Cardiovascular Medicine297
- Oncology239
- Infectious Diseases234
- Epidemiology204
- Neurology172
- Radiology, Nuclear Medicine and Imaging170
- Endocrinology, Diabetes and Metabolism163
- Physiology163
- Psychiatry and Mental health145
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology99
- Hematology83
- Obstetrics and Gynecology83
- Rheumatology67
- Nephrology61
- Pharmacology54
- Complementary and alternative medicine50
- Reproductive Medicine49
- Emergency Medicine45
- Geriatrics and Gerontology39
- Rehabilitation37
- Otorhinolaryngology35
- Hepatology29
- Pathology and Forensic Medicine26
- Critical Care and Intensive Care Medicine24
- Immunology and Allergy23
- Genetics20
- Anesthesiology and Pain Medicine14
- Urology14
- Gastroenterology6
- Health Informatics5
- Internal Medicine5
- Transplantation3
- Family Practice2
- Biochemistry1
- Anatomy0
- Microbiology0
163 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2020. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2018–2020, the window the 2021 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2018–2020 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2012 to 2021. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 8.84Q1 | 25.65 2.86 up from 2020 | 133 | 91% | $3,750 | ||
2The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands | 6.01Q1 | 19.89 4.63 up from 2020 | 470 | 52% | $7,280 | ||
3Diabetes CareAmerican Diabetes Association · United States | 4.59Q1 | 14.26 0.54 down from 2020 | 1,484 | 81% | — | ||
4DiabetologiaSpringer Science+Business Media · Germany | 3.48Q1 | 10.29 0.04 down from 2020 | 724 | 96% | $3,490 | ||
5Journal of Internal MedicineWiley · United Kingdom | 2.96Q1 | 11.82 4.16 up from 2020 | 436 | 72% | $4,780 | ||
6Cardiovascular DiabetologyOABioMed Central · United Kingdom | 2.95Q1 | 9.39 1.71 down from 2020 | 537 | 100% | $4,290 | ||
7Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 2.76Q1 | 7.21 1.10 up from 2020 | 197 | 35% | $4,450 | ||
8Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 2.69Q1 | 11.01 3.49 up from 2020 | 163 | 63% | $5,590 | ||
9Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.49Q1 | 5.49 0.34 down from 2020 | 160 | 20% | $3,540 | ||
10European Journal of EndocrinologyOxford University Press · United Kingdom | 2.47Q1 | 6.84 0.38 down from 2020 | 487 | 47% | $4,292 | ||
11Current Diabetes ReportsSpringer Science+Business Media · United States | 2.45Q1 | 6.81 0.58 up from 2020 | 381 | 48% | $4,890 | ||
12Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 2.33Q1 | 7.65 1.16 up from 2020 | 432 | 52% | — | ||
13Diabetes & Metabolic Syndrome Clinical Research & ReviewsElsevier BV · Netherlands | 2.24Q1 | 13.44 10.30 up from 2020 | 1,035 | 41% | $4,450 | ||
14Frontiers in EndocrinologyOAFrontiers Media · Switzerland | 2.09Q1 | 7.01 0.45 up from 2020 | 2,599 | 100% | $3,801 | ||
15The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 2.07Q1 | 6.15no change | 2,092 | 90% | $3,750 | ||
16Journal of DiabetesOAWiley · Australia | 1.99Q1 | 3.67 4.08 down from 2020 | 365 | 48% | $3,000 | ||
17ThyroidMary Ann Liebert, Inc. · United States | 1.98Q1 | 6.44 0.08 up from 2020 | 663 | 39% | — | ||
18Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.97Q1 | 8.70 4.00 up from 2020 | 420 | 40% | $4,780 | ||
19Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.96Q1 | 8.39 1.99 up from 2020 | 1,240 | 40% | $4,410 | ||
20Pediatric DiabetesWiley · Denmark | 1.92Q1 | 3.44 2.31 down from 2020 | 486 | 59% | $2,740 | ||
21Diabetes Obesity and MetabolismWiley · United Kingdom | 1.84Q1 | 6.51 0.34 up from 2020 | 999 | 57% | $5,380 | ||
22Clinical Diabetes and EndocrinologyOABioMed Central · United Kingdom | 1.79Q1 | 5.49 0.04 down from 2020 | 61 | 100% | $2,290 | ||
23Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.75Q1 | 7.03 2.63 up from 2020 | 309 | 100% | $2,890 | ||
24JMIR DiabetesOACanada | 1.67Q1 | 3.80 0.42 down from 2020 | 79 | 100% | $1,873 | ||
25Journal of Endocrinological InvestigationSpringer Science+Business Media · Italy | 1.66Q1 | 5.82 2.10 up from 2020 | 632 | 49% | $4,790 | ||
26BMJ Open Diabetes Research & CareOABMJ · United Kingdom | 1.64Q1 | 5.10 0.53 up from 2020 | 551 | 100% | $3,000 | ||
27Endocrine Related CancerBioscientifica · United Kingdom | 1.63Q1 | 5.68 0.24 up from 2020 | 339 | 67% | — | ||
28MaturitasElsevier BV · Netherlands | 1.63Q1 | 5.76 1.02 up from 2020 | 503 | 29% | $4,390 | ||
29European Thyroid JournalOAKarger Publishers · Switzerland | 1.63Q1 | 4.34 0.29 down from 2020 | 170 | 97% | — | ||
30Journal of EndocrinologyBioscientifica · United Kingdom | 1.58Q1 | 4.83 0.50 up from 2020 | 400 | 90% | — | ||
31Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 1.57Q1 | 4.90 0.03 up from 2020 | 762 | 100% | $2,760 | ||
32Therapeutic Advances in Endocrinology and MetabolismOASAGE Publishing · United Kingdom | 1.57Q1 | 5.38 1.13 up from 2020 | 152 | 100% | $2,650 | ||
33EndocrinologyOxford University Press · United States | 1.56Q1 | 4.86 0.32 up from 2020 | 753 | 94% | $3,750 | ||
34Diabetes & MetabolismElsevier BV · Netherlands | 1.54Q1 | 6.72 2.43 up from 2020 | 256 | 45% | $4,490 | ||
35Expert Review of Endocrinology & MetabolismTaylor & Francis · United Kingdom | 1.51Q1 | 4.04 0.14 down from 2020 | 102 | 33% | — | ||
36PituitarySpringer Science+Business Media · Netherlands | 1.47Q1 | 4.45 0.45 up from 2020 | 238 | 55% | $4,490 | ||
37Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.46Q1 | 5.12 0.52 up from 2020 | 769 | 100% | $2,990 | ||
38Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 1.45Q1 | 3.85 0.65 up from 2020 | 178 | 42% | — | ||
39World Journal of DiabetesOAHong Kong SAR China | 1.43Q1 | 5.39 0.57 up from 2020 | 140 | 100% | — | ||
40Clinical Medicine Insights Endocrinology and DiabetesOASAGE Publishing · United States | 1.40Q1 | 5.27 1.50 up from 2020 | 48 | 100% | $2,650 | ||
41touchREVIEWS in EndocrinologyOATouch Medical Media · United Kingdom | 1.35Q1 | 3.98 0.04 down from 2020 | 72 | 100% | — | ||
42Journal of the Endocrine SocietyOAEndocrine Society · United States | 1.32Q2 | 3.92 0.12 up from 2020 | 549 | 100% | $3,255 | ||
43BMC Endocrine DisordersOABioMed Central · United Kingdom | 1.32Q2 | 4.15 0.68 up from 2020 | 424 | 100% | $3,190 | ||
44Thyroid ResearchOABioMed Central · United Kingdom | 1.31Q2 | 2.87 0.23 down from 2020 | 47 | 100% | $2,790 | ||
45Expert Review of Clinical PharmacologyTaylor & Francis · United Kingdom | 1.30Q2 | 4.31 1.09 down from 2020 | 313 | 29% | — | ||
46Diabetes & Metabolism JournalOAKorean Diabetes Association · South Korea | 1.28Q2 | 4.69 0.22 down from 2020 | 308 | 100% | $500 | ||
47International Journal of EndocrinologyOAHindawi Publishing Corporation · United Kingdom | 1.26Q2 | 3.30 0.70 down from 2020 | 529 | 100% | $2,830 | ||
48International Journal of Chronic DiseasesHindawi Publishing Corporation · United Kingdom | 1.26Q2 | 2.77 3.70 down from 2020 | 36 | 100% | $800 | ||
49Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.25Q2 | 4.36 0.06 up from 2020 | 699 | 32% | $3,000 | ||
50Clinical EndocrinologyWiley · United Kingdom | 1.25Q2 | 3.40 0.66 down from 2020 | 637 | 40% | $4,250 |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery985
- Pulmonary and Respiratory Medicine362
- Public Health, Environmental and Occupational Health303
- Cardiology and Cardiovascular Medicine297
- Oncology239
- Infectious Diseases234
- Epidemiology204
- Neurology172
- Radiology, Nuclear Medicine and Imaging170
- Endocrinology, Diabetes and Metabolism163
- Physiology163
- Psychiatry and Mental health145
- Orthopedics and Sports Medicine124
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology99
- Hematology83
- Obstetrics and Gynecology83
- Rheumatology67
- Nephrology61
- Pharmacology54
- Complementary and alternative medicine50
- Reproductive Medicine49
- Emergency Medicine45
- Geriatrics and Gerontology39
- Rehabilitation37
- Otorhinolaryngology35
- Hepatology29
- Pathology and Forensic Medicine26
- Critical Care and Intensive Care Medicine24
- Immunology and Allergy23
- Genetics20
- Anesthesiology and Pain Medicine14
- Urology14
- Gastroenterology6
- Health Informatics5
- Internal Medicine5
- Transplantation3
- Family Practice2
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2021. Corpus-wide, 87.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
57 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2018–2020, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2021. Publication window: 2018–2020. How these summaries are calculated
- Ranked journals
- 163
- Window papers (baseline)
- 75,894 +11.0% from indicator year 2018
- Median OJR
- 0.8896 -6.4% from indicator year 2018
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2018–2020 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.